The aim of this study was to investigate the feasibility of noninvasive monitoring of plaque burden in apolipoprotein E-deficient (ApoE 2/2 ) mice by Gadospin F (GDF)-enhanced magnetic resonance imaging (MRI). Gadolinium uptake in plaques was controlled using transmission electron microscopy (TEM) and x-ray fluorescence (XRF) microscopy. To monitor the progression of atherosclerosis, ApoE 2/2 (n 5 5) and wild-type (n 5 2) mice were fed a Western diet and imaged at 5, 10, 15, and 20 weeks.
A THEROSCLEROSIS is characterized by the formation of inflammatory plaques that occupy the intimal layer of arterial walls. Despite advances in understanding of the pathogenesis of atherosclerosis, resulting cardiovascular diseases such as cardiac infarction, stroke, and renal failure remain the main cause of mortality in industrialized and developing nations. 1 Growing evidence suggests that the decisive factor determining plaque vulnerability is more dependent on the plaque configuration than on the degree of luminal narrowing. 2, 3 However, luminographic techniques, such as conventional angiography and contrastenhanced computed tomography (CT) or magnetic resonance angiography, are still used in the clinical diagnostic, although these techniques underestimate the true burden of atherosclerosis. 4 Recent improvements in conventional and specifically molecular magnetic resonance imaging (MRI) proved to be a promising tool in allowing evaluation of plaque composition at the cellular and molecular levels, thus improving the discrimination between stable and vulnerable plaque. 5, 6 In particular, contrast-enhanced MRI using extracellular gadolinium (Gd)-based contrast agents has shown promise for highlighting specific plaque components. 7, 8 Gadofluorine M (GDM; Bayer Schering Pharma AG, Berlin-Wedding, Germany) has been described as a reliable, noninvasive tool to identify and quantify plaque burden in animal models of atherosclerosis 9 as it binds to plaque and specifically targets the extracellular matrix of plaque, 10 thus making it an important marker of plaque staging. 11 Furthermore, a Gd-labeled elastin-specific magnetic resonance contrast agent (ESMA) that allows visualization and quantification of atherosclerotic plaque burden in apolipoprotein E-deficient (ApoE 2/2 ) mice at 3 T MRI has been reported. 12 Gadospin F (GDF; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) is an amphiphilic Gd-based contrast agent with a high protein-binding affinity specifically formulated for preclinical MRI. With a perfluorinated side chain, it is similar to GDM; however, it has not been established for preclinical 7 T MRI studies on ApoE 2/2 mice, and the sensitivity and specificity of this contrast agent for monitoring plaque progression are not yet known.
Typically, well-established ApoE 2/2 mice are used for the evaluation of atherosclerotic disease. 13, 14 Examination by noninvasive imaging techniques is preferable as longitudinal preclinical studies on the development of plaque burden, the progression of disease, and the evaluation of therapy response become more reliable. The first sites examined for the development of plaques included the aortic root, the lesser curvature of the aortic arch, the branches of the brachiocephalic artery, and the right common carotid artery. 14 To get an ideal spatial and chemical resolution of GDF within the aortic plaque, imaging analysis was performed using x-ray fluorescence (XRF) microscopy, which, to the best of our knowledge, has not been reported previously. We obtained precise trace element ion maps in situ of atherosclerotic tissues and the spatial distribution of Gd and other metal ion localizations, such as P, S, Cl, K, Ca, Zn, Cu, and Fe, in this specific compartment of aorta tissue. We used the original double ring store (DORIS III) as a dedicated synchrotron radiation source at DESY (Hamburg, Germany), and the circumference of 289 meters allowed us to store positrons and electrons at an energy of 4.45 GeV and in a bunched package. The DESY campus at Hamburg (there is another campus at Zeuthen near Berlin) is one of the most intense x-ray sources in the world. The radiation in the extreme ultraviolet and x-ray regimen is used in a broad range of applications, from biology and chemistry to materials science, for example, to characterize the complex anatomic structures of the human inner ear. 15 In this study, we established a reliable and easy to use imaging strategy to define plaque burden by using GDF, an amphiphilic small-molecular-weight MRI contrast agent. The focus was put on a short imaging time without electrocardiography (ECG) or respiratory triggering while still keeping good image quality. Moreover, the efficacy of GDF to assess plaque progression by signal intensity measurements was evaluated. Additionally, the localization and distribution pattern of GDF within the atherosclerotic plaque were verified by transmission electron microscopy (TEM) and XRF microscopy.
Material and Methods
Contrast Agent GDF has a low molecular weight (1.3 g/mol) and is a derivate of Gd-DO3A, containing a perfluorinated side chain. GDF has an r1 relaxivity of 18 mmol/L -1 s -1 in plasma and 15 mmol/L -1 s -1 in water (1.5 T and 37uC). Due to the hydrophobic character of the fluorinated side chain, GDF assembles like small aggregates or micelles in diluted solution. The driving force is the hydrophobic character of the fluorinated site chain. Therefore, GDF is lipophilic compared to agents such as Gd-diethylene triamine pentaacetic acid (DTPA) but is water soluble.
Animals
All B6.129P2-apoE tm1Unc/J (C57BL/6J background) mice (ApoE 2/2 ) were purchased from Charles River Laboratories/Jackson Laboratories (Bar Harbor, ME) and were housed in the animal unit of the University Medical Center Hamburg-Eppendorf, Germany. C57BL/6J wild-type mice were used as controls. ApoE 2/2 mice were fed a Western diet (ssniff EF R/M from TD88137 mod., ssniff Spezialdiäten GmbH, Soest, Germany) to induce atherosclerotic plaques.
Magnetic Resonance Imaging
MRI examinations were performed using a 7 T preclinical animal MRI scanner (Bruker Clinscan, Ettlingen, Germany). Animals were anesthetized with 1 to 2% isoflurane in O 2 gas mixture with a flow rate of 600 mL/min. The vital parameters were controlled by measuring the respiratory breathing cycle (SA Instruments, Stony Brook, NY), and the body temperature was maintained at 37uC during examination using a water-bed heating system. A four-channel mouse surface coil, with a coil diameter of 20 mm for signal receiving and a rat body coil for radiofrequency transmission, was used (Bruker, Ettlingen, Germany). The scan protocol included the survey scan followed by a parasagittal T 1 -weighted two-dimensional (2D) turboflash sequence to cover the aortic arch ( Figure 1 , Table 1 ). Based on the parasagittal scan, the T 1 -weighted, three-dimensional (3D) inversion recovery sequence was planned in transversal direction, covering the thoracic aorta. No ECG or breath triggering was used.
Earlier and Late Contrast-Enhanced MRI
To determine the signal intensity (SI) in blood over time of GDF in vivo, ApoE 2/2 mice (n 5 3) were scanned using the 3D inversion recovery sequence (see Table 1 ), each for 10 minutes. First, a scan to determine the baseline was performed before GDF (100 mmol/kg) was injected intravenously followed by MRI for 2 hours.
Monitoring Disease Progression by MRI
ApoE 2/2 mice (n 5 5, 16 weeks old) and wild-type mice (n 5 2, 16 weeks old) were fed a high-fat diet (HFD) for a period of 20 weeks. To follow disease progression, animals were imaged after 5, 10, 15, and 20 weeks of the HFD. Images were obtained before and 2 hours after intravenous injection of GDF (100 mmol/kg).
Image Analysis
MRIs were analyzed by Image Processing and Analysis in Java (ImageJ, version 1.45, National Institutes of Health, Bethesda, MD). To obtain blood clearance, regions of interest (ROI) were placed in the ascending aorta and muscle, and intensities of every single image in a time series S(t) were exported and normalized to the average intensity S 0 contrast before GDF injection. Moreover, ROI were placed in muscle and plaque, as seen in Figure 1 , for each slice to estimate plaque size and CNR. Plaque area was calculated by adding the single plaque ROI of each slice. To determine the CNR over time in the plaque of the aortic root and the brachiocephalic artery, the signal difference relative to the muscle was calculated according to the following equation:
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Statistical Analysis
Statistical analysis was performed using GraphPad Prism 5 (GraphPad Software, La Jolla, CA). Values are expressed as means 6 standard error of the mean (SEM). For all statistical comparisons, a Student t-test (unpaired, twotailed) was applied. The size and CNR of plaque were compared using Pearson correlation coefficient to assess the validity. Correlation coefficients . 0.7 were considered strong, 0.7 to 0.5 moderate, 0.5 to 0.3 weak, and 0.3 to 0 almost nonexistent. Probability values , .05 were considered statistically significant. 
Transmisson Electron Microscopy
For TEM analysis, mice were perfused with 2.5% glutaraldehyde and 4% paraformaldehyde and aortas were removed from surrounding tissue. After preselection of the aortic plaque areas by light microscopy, the samples were postfixed with 1% osmium in phosphate-buffered saline (PBS) and 0.5% gallic acid in PBS, dehydrated, and embedded in EPON resin. For the evaluation of the Gd contrast by TEM, samples were prepared according to the Tokuyasu cryosectioning technique protocol, excluding the uranyl acetate staining to prevent false-positive findings. 16 To compare the TEM analysis of native aortic sections to GDF-injected sections, the settings of the camera and the acquisition software were equal. Images were acquired with a Philips CM120 electron microscope equipped with a BioTWIN lens and a Gatan MSC 794 Camera (Gatan GmbH, München, Germany).
XRF Imaging
XRF imaging was performed at beamline L at the synchrotron light source DORIS III, and sample preparation was performed as previously described. 17 Briefly, immediately after tissue isolation, 20 mm thin cross sections were prepared using a cryomicrotome (Leica, Biosystems, Wetzlar, Germany). The samples were directly attached to a 200 nm thick silicon-nitride membrane, freeze-dried, and stored over silica gel in a desiccator prior to x-ray measurements. Hard x-ray microscopy at E 5 10.2 keV was used to mainly target Gd L emission lines and K lines of P, S, Cl, K, Ca, Zn, Cu, and Fe. To identify Gd, two L lines were chosen: La1 at 6057.2 eV and Lb1 at 6137.2 eV. The experimental setup included a multilayer monochromator for high-photon flux and a polycapillary half-lens to focus the incoming x-ray beam to a spot of 15 mm diameter. A silicon drift detector positioned at 90u to the incoming x-ray beam equipped with a standard collimator with a 2 mm pinhole was used to collect the fluorescence signal. A 100 mm thick National Institute of Standards and Technology standard (mM 612) measured with the same setup was used for signal calibration to allow quantification of element concentrations in the samples. Two-dimensional maps were created by scanning the sample through the x-ray beam. At each point, XRF spectrum was collected. The spectra were subsequently fitted using AXIL (IAEA Laboratories Seibersdorf, Seibersdorf, Austria) and PyMca (ESRF, Grenoble, France) softwares. 18, 19 
Ethics Statement
The experiment was supervised by the institutional animal welfare officer and approved by the local licensing authority (Behörde für Soziales, Familie, Gesundheit und Verbraucherschutz, Amt für Gesundheit und Verbraucherschutz, Hamburg, Germany, project no. 33/10).
Results

Earlier and Late Contrast-Enhanced MRI
Earlier and late contrast-enhanced MRIs revealed that 2 hours after intravenous application of GDF, the majority of the contrast agent was cleared from the blood, so the vessel lumen appeared dark on T 1 -weighted MRIs, as seen prior to injection ( Figure 2 ). Muscle tissue was used as a control because it showed low uptake.
Plaque Detection and Disease Monitoring by MRI
Significant signal enhancement along the aortic arch was achieved 2 hours after injection of GDF in ApoE 2/2 mice, whereas no signal differences between pre-and postcontrast images were detected in wild-type mice (see Figure 2 ). At that time point, GDF was completely cleared from the blood. When imaging was repeated 2 days postinjection, the observed signal enhancement in the plaque of ApoE 2/2 mice completely vanished.
To monitor disease progression by MRI, GDF was injected into five ApoE 2/2 mice at four different time points on the HFD and images were taken before and 2 hours after GDF application. A gradual and considerable increase in plaque CNR on MRI was observed for all time points ( Figure 3 ). These temporal changes in plaque CNR of the aortic root ( Figure 4 ) were significantly different between mice on an HFD for 10 and 15 weeks (p , .001) and for 15 and 20 weeks (p , .001), whereas no significant differences were detected by CNR between the group on an HFD for 5 and 10 weeks. The CNR for brachiocephalic plaque over time ( Figure 3B ) was significantly different between 5 and 10 weeks (p , .01) and 15 and 20 weeks (p , .001), whereas no significant difference was measurable between 10 and 15 weeks.
These temporal changes in plaque CNR were in agreement with the estimated progression in plaque size (see Figure 4A ). For the aortic root, plaque size increased from 0.52 6 0.01 mm 3 after 5 weeks on an HFD to 0.83 6 0.01 mm 3 after 10 weeks (p , .01), to 1.57 6 0.02 mm 3 (p , .001), and to 2.25 6 0.01 mm 3 after 20 weeks (p , .001). Plaque size in the brachiocephalic artery was smaller but also increased gradually and substantially over time. After 5 weeks on an HFD, the plaque size was 0.15 6 0.01 mm 3 ; after 10 weeks, 0.26 6 0.02 mm 3 (p , .001); after 15 weeks, 0.37 6 0.02 mm 3 (p , .05); and after 20 weeks, 0.54 6 0.02 mm 3 (p , .01).
Plaque size and CNR measurements in the aortic root revealed a strong correlation (r 5 .787; p , .01; 95% confidence interval). Correlation between plaque size and the CNR of the brachiocephalic artery was somewhat lower but still moderate (r 5 .682; p , .01; 95% confidence interval).
Transmission Electron Microscopy
The contrast of uninjected ( Figure 5A ) and post-GDFinjected aortic plaque ( Figure 5E ) images obtained by TEM of conventionally stained with uranyl acetate/osmium tetroxide and resin-embedded samples is similar. The images show a cross section of a typical peripheral plaque area with endothelial cells and foam cell residues. Gd of the GDF could not be detected from contrast differences within the aortic plaque by using conventional TEM. However, after performing TEM analysis of the unstained Tokuyasu cryosections, the contrast of the aortic plaque injected with GDF is higher ( Figure 5 , F and H) compared to the control (Figure 5 , B-D) as Gd acts as a known electron-dense material.
XRF Imaging
To determine the Gd distribution within the plaque after GDF injection, we performed an XRF study of aortic 20 mm thick cross sections after MRI analysis. Figure 6 shows a typical image taken with the XRF microscope. The image was collected of an area of 320 3 1,140 mm, with 32 3 114 pixels with a dwell time of 10 seconds per pixel. The absolute area concentration is expressed in arbiter units (color bar). Figure 6A shows the summed fluorescence spectrum collected from a freezedried cross section of atherosclerotic tissues, previously observed in MRI ( Figure 6B ) and visible by light microscopy ( Figure 6C ). The fluorescence maps of Gd L lines and K lines of Fe, Ca, Zn, P, S, Cl, K, and Cu are shown in Figure 6D . By using two L emission lines of Gd (Gd La1 Gd Lb1) (see Figure 6D ) from the fluorescence spectra ( Figure 6A) , we were clearly able to localize the GDF in the tissue. Strong Gd contributions, as well as P, S, Figure 2 . Plaque imaging and blood clearance by MRI. Parasagittal slice orientation through the aortic arch. Atherosclerotic plaques were not detectable on precontrast scans (A). A significant signal enhancement within the atherosclerotic plaque along the aortic arch was achieved 2 hours after intravenous injection of GDF in ApoE 2/2 mice (B), which were fed on a high-cholesterol diet for 20 weeks. Signal enhancement was completely lost 2 days after injection (C). No signal difference was detectable in the wild-type mice (control) (D, E). The white arrows are pointed at aortic plaque lesions along the aortic arch. Earlier and late contrast-enhanced MRIs (F) of ApoE 2/2 mice showed the highest signal intensity within the blood after 10 minutes and exhibited a continuous decrease over the next 2 hours. Contrast agent was cleared from blood 2 hours after application of GDF. Muscle as control tissue showed no GDF uptake. a 5 aortic root; b 5 brachiocephalic artery; c 5 carotid artery; p 5 pulmonary artery; s 5 subclavian artery; SI 0 5 signal intensity contrast before injection of GDF; SI(t) 5 signal intensity at the different time points after injection of GDF.
Detection of Atherosclerosis in ApoE 2/2 Mice at 7 T MRI Ca, K, and Zn, were observed in the plaque. However, Fe was differently localized than Gd within that particular tissue, whereas S and Cl were distributed quite homogeneously over the whole aorta cross section (see Figure 6 , D and E). The overlaying images (see Figure 6 , E and F) show the colocalization of the Gd and P, probably originating from the phospholipids.
Discussion
In the present study, we performed multimodal imaging of atherosclerotic tissue in mice. We established the detection of atherosclerotic plaques in ApoE 2/2 mice at 7 T MRI by using GDF, an amphiphilic small-molecular-weight MRI contrast agent. Earlier and late contrast-enhanced MRIs determined the optimal time point for plaque imaging 2 hours after intravenous injection. Changes in plaque development at various stages of atherosclerotic disease were assessed through CNR calculation, which increased over time and was proportional to the increase in plaque size. A moderate to strong correlation could be achieved between plaque size and CNR measurements. TEM analysis from ultramicrotome aortic sections 16 further proved that post-GDF sections seemed to be higher in contrast than plaques not injected with GDF. In addition, we were able to confirm the elementary structure of GDFbound Gd within the plaque by XRF microscopy.
Gd-based contrast agents are known to distribute into the extracellular fluid space, and the detection of atherosclerotic plaques using Gd-DTPA, GDM, or Gd-labeled ESMA has been described before. 10, 12, 20, 21 Recently, Gd-DTPA was applied to image atherosclerosis in human subjects by surface MRI. [22] [23] [24] When T 1 -weighted surface MRI was applied, a 29 to 80% increase in signal intensity of fibrous tissue with Gd-DTPA in carotid arteries occurred. 22, 24 This is typically limited to one vascular bed Figure 3 . Monitoring of plaque progression by contrast to noise ratio (CNR) estimation. The temporal changes in plaque CNR of the aortic root were significantly different between 10 and 15 weeks (p , .001) and 15 and 20 weeks (p , .001), whereas no significant differences were detectable in the CNR between 5 and 10 weeks. The CNR over time for brachiocephalic plaque was significantly different between 5 and 10 weeks (p , .01) and 15 and 20 weeks (p , .001), whereas the difference between 10 and 15 weeks was not significant. The white arrows are pointed at the vessel wall of the aortic root or brachiocephalic artery. a 5 aortic root; b 5 brachiocephalic artery.
(or even one MRI slice) due to the rapid wash-in/out plaque kinetics of currently approved agents, including Gd-DTPA. This leads to a short imaging window of about 20 minutes and limits the use of these agents for imaging multiple plaques in different vascular beds. 21 Due to the short imaging window, which is even smaller in mice, the use of Gd-DTPA in ApoE 2/2 mouse models for the detection and estimation of CNR in atherosclerotic plaque is, from our experience, not feasible. The wash-in/out plaque kinetic of GDF is slower, making it a reliable tool for the diagnosis of atherosclerosis in preclinical animal studies. The diagnosis of atherosclerotic plaque even at early stages using GDF is feasible. A disadvantage of GDM is the late imaging time point, 2 days after intravenous injection, no matter if rabbits or mice were used as an animal model. Compared to GDM, the best imaging time point for GDF used in the same concentration is 2 hours after intravenous injection.
The high-resolution MRI protocol enables us to quantify plaque burden by CNR and plaque size measurements. The differentiation between early and advanced plaques according to the CNR was also shown in New Zealand White rabbits in different young (fed on an HFD for 2 months) and older (fed on an HFD for 8 months) animals. 9 Our results proved that the monitoring of plaque progression within the same ApoE 2/2 mouse at 7 T MRI with short time intervals of 5 weeks is realistic. We achieved significant differences for almost all time points for the aortic root and the brachiocephalic artery. This . Monitoring of plaque progression by plaque size estimation and in correlation with contrast to noise ratio (CNR) measurements. For the aortic root, the plaque size increased from 0.52 6 0.01 mm 3 after 5 weeks on a high-cholesterol diet to 0.83 6 0.01 mm 3 after 10 weeks (p , .01), to 1.57 6 0.02 mm 3 (p , .001) and to 2.25 6 0.01 mm 3 after 20 weeks (p , .001) (A). Plaque size in the brachiocephalic artery was smaller but also gradually increased over time. After 5 weeks on a high-cholesterol diet, the plaque size was 0.15 6 0.01 mm 3 ; after 10 weeks, 0.26 6 0.02 mm 3 (p , .001); after 15 weeks, 0.37 6 0.02 mm 3 (p , .05); and after 20 weeks, 0.54 6 0.02 mm 3 (p , .01) (A). A strong correlation was achieved for plaque size and CNR measurements in the aortic root (r . .78; p , .001) (B), whereas a moderate correlation was determined between plaque size and CNR measurements of the brachiocephalic artery (r . .68; p , .01) (C).
Detection of Atherosclerosis in ApoE 2/2 Mice at 7 T MRI may help in the discovery of novel therapeutics that slow or reverse the disease and represents a good tool for preclinical longitudinal MRI studies.
To analyze the distribution pattern of GDF within atherosclerotic plaque and to establish a second-line tool for the detection of GDF within the aortic plaque, TEM and XRF analysis was performed. To the best of our knowledge, TEM and XRF analysis of atherosclerotic plaque to prove the uptake of GDM or GDF has not been reported previously. Makowski and colleagues showed the specific distribution of Gd-labeled ESMA by TEM. 12 However, to clarify the detection of Gd, a microscope was equipped with an EDAX energy dispersive spectroscopy detector (EDAX, Mahwah, NJ). The evidence of Gd-DTPA within neural and mesenchymal stem cells has also been performed by TEM. 25, 26 In those cells, the Gd-DTPA forms clusters, which make visualization much easier. That Gd acts as an electrondense material was also confirmed by the study of Cao and colleagues, in which Gd nanoparticles were synthesized and the spherical shapes were analyzed by TEM. 27 In agreement with those studies, our TEM analysis was evaluated without uranyl acetate staining to prevent false-positive findings. Thus, we did not detect clear differences between the GDFtreated plaque and the negative control, the native plaque, by TEM of resin-embedded samples. This may be due to the fact that the GDF is diffusely distributed within the plaque. This is in accordance with the electron microscopy analysis of dermal deposits in a patient with nephrogenic systemic fibrosis. Here the question of whether anorganic material deposits such as calcium and/or magnesium also contain Gd 28 remained unsolved. However, when the aortic sections were prepared according to the Tokuyasu cryosectioning protocol, we achieved a higher contrast for the injected plaque compared to the control due to the fact that Gd acts as an electron-dense material. [25] [26] [27] The XRF analysis provided elemental mappings, especially Gd, in situ within the atherosclerotic plaque. It is possible to distinguish clearly the part of the plaque where Gd was localized (see Figure 6 ). The measurements of the typical Gd mapping within the plaque were in agreement with previous studies. 12 We observed a pronounced enrichment of Gd in the atherosclerotic mouse tissues. Until now, XRF was not used for the detection of GDF in atherosclerotic plaques; however, this method gave an ideal spatial and chemical resolution to answer the question of where the Gd-lipid deposits are localized in the aorta. We were also able to detect the endogenous elements P, K, Ca, Cl, S, Fe, Cu, and Zn, which has not been shown before. In the long term, this analytical method represents a good opportunity to make eventual diagnosis in the early stages of disease.
Limitations
This study has several limitations. As the aim of the study was to evaluate plaque progression for the same individual over time, we did not perform a correlation of plaque size and CNR to histologic analysis. Sometimes it was difficult for the wild-type mice and the first measured time point at 5 weeks on an HFD to discriminate the vessel and the aortic plaque from surrounding tissue. Also, for TEM analysis, only a small section of the atherosclerotic plaque can be included. Although electron microscopy requires relatively invasive sample preparation, typically including fixation and thin slicing of the sample, x-ray microscopy can provide spectra without the risk of changing the cell organization by chemical fixation. Another important difference with respect to TEM-EDAX (Energy Disperse X-Ray Analysis) is related to the depth of the probe. Whereas EDAX is surface sensitive to the outer molecular layers, XRF excited by synchrotron radiation also collects signal from entire 20 mm thick sections.
Conclusion
We demonstrated the successful use of GDF-enhanced MRI at 7 T for atherosclerotic plaque detection in ApoE 2/2 mice. The optimal time point for plaque imaging was determined 2 hours after GDF injection. Due to the assessment of changes in plaque sizes and CNR at various stages of atherosclerosis, the monitoring of plaque progression is feasible. In addition, we were able to show that the detection of GDF by TEM (Tokuyasu) and by XRF microscopy within the atherosclerotic plaque is reliable.
